This compound is a chiral pharmaceutical intermediate featuring a complex cyclopenta-dioxolane core structure with an ethyl ester and a benzyloxycarbonyl-protected amine group. It is used in the synthesis of active pharmaceutical ingredients.
Portée du contenu: Les informations de cette page concernent l'identification chimique ainsi que les contextes d'approvisionnement industriel, de recherche et de production. Elles ne constituent ni une allégation thérapeutique, ni un avis médical, ni une notice d'utilisation médicamenteuse.
Approvisionnement ou fourniture de ce composé?
Publiez votre inventaire ou une demande d'achat
CAS 866551-95-3
Phenylmethyl N-[(3aS,4R,6S,6aR)-tetrahydro-6-(2-hydroxyethoxy)-2,2-dimethyl-4H-cyclopenta-1,3-dioxol-4-yl]carbamate
Pharmaceutical intermediate synthesis
(S)-1-(3,4-Dimethoxybicyclo[4.2.0]octa-1,3,5-trien-7-yl)-N-methylmethanamine
Ivabradine hydrochloride impurity D
2,2,2-trifluoro-1-(piperidin-4-yl)ethan-1-one
Pharmaceutical intermediate
Triethyl phosphonoacetate
Horner-Wadsworth-Emmons reaction reagent
S-Methylisothiourea hemisulfate
pharmaceutical intermediate
Carbamic acid, N-((3aS,4R,6S,6aR)-tetrahydro-6-hydroxy-2,2-dimethyl-4H-cyclopenta-1,3-dioxol-4-yl)-, phenylmethyl ester
Pharmaceutical intermediate with acetal and carbamate groups
ethyl 2-[[(3aR,4S,6R,6aS)-2,2-dimethyl-6-(phenylmethoxycarbonylamino)-4,5,6,6a-tetrahydro-3aH-cyclopenta[d][1,3]dioxol-4-yl]oxy]acetate
LMOJGNUNTMQCBQ-MXSMSXNCSA-N
CCOC(=O)CO[C@H]1C[C@H]([C@H]2[C@@H]1OC(O2)(C)C)NC(=O)OCC3=CC=CC=C3
—